NWZLX
Price
$21.51
Change
+$0.11 (+0.51%)
Updated
Sep 26 closing price
Net Assets
228.65M
RGACX
Price
$84.36
Change
+$0.32 (+0.38%)
Updated
Sep 26 closing price
Net Assets
336.88B
Interact to see
Advertisement

NWZLX vs RGACX

Header iconNWZLX vs RGACX Comparison
Open Charts NWZLX vs RGACXBanner chart's image
Nationwide Loomis All Cap Gr A
Price$21.51
Change+$0.11 (+0.51%)
VolumeN/A
Net Assets228.65M
American Funds Growth Fund of Amer R3
Price$84.36
Change+$0.32 (+0.38%)
VolumeN/A
Net Assets336.88B
NWZLX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NWZLX vs. RGACX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWZLX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 337B vs. NWZLX (229M). RGACX pays higher dividends than NWZLX: RGACX (0.07) vs NWZLX (0.00). NWZLX was incepted earlier than RGACX: NWZLX (8 years) vs RGACX (23 years). NWZLX (1.36) is less costly to investors than RGACX (0.94). RGACX is a more actively managed with annual turnover of: 25.00 vs. NWZLX (8.16). RGACX has a lower initial minimum investment than NWZLX: RGACX (250) vs NWZLX (2000). NWZLX annual gain was more profitable for investors over the last year : 14.97 vs. RGACX (12.22). RGACX return over 5 years is better than : 45.63 vs. NWZLX (41.89).
NWZLXRGACXNWZLX / RGACX
Total Expense Ratio1.270.94135%
Annual Report Gross Expense Ratio1.360.94145%
Fund Existence8 years23 years-
Gain YTD15.95717.18393%
Front Load6%N/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets229M337B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year14.9712.22122%
Returns for 3 years82.7571.26116%
Returns for 5 years41.8945.6392%
Returns for 10 yearsN/A111.15-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTGN3.530.16
+4.75%
VistaGen Therapeutics
SMMT20.950.69
+3.41%
Summit Therapeutics
IBO0.660.01
+1.53%
Impact BioMedical Inc.
SMPL24.71-0.07
-0.28%
Simply Good Foods Company (The)
JFIN10.48-0.24
-2.24%
Jiayin Group